<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34642875</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Long-term health sequelae and quality of life at least 6&#xa0;months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).</ArticleTitle><Pagination><StartPage>1277</StartPage><EndPage>1287</EndPage><MedlinePgn>1277-1287</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-021-01707-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Over the course of COVID-19 pandemic, evidence has accumulated that SARS-CoV-2 infections may affect multiple organs and have serious clinical sequelae, but on-site clinical examinations with non-hospitalized samples are rare. We, therefore, aimed to systematically assess the long-term health status of samples of hospitalized and non-hospitalized SARS-CoV-2 infected individuals from three regions in Germany.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The present paper describes the COVIDOM-study within the population-based cohort platform (POP) which has been established under the auspices of the NAPKON infrastructure (German National Pandemic Cohort Network) of the national Network University Medicine (NUM). Comprehensive health assessments among SARS-CoV-2 infected individuals are conducted at least 6&#xa0;months after the acute infection at the study sites Kiel, W&#xfc;rzburg and Berlin. Potential participants were identified and contacted via the local public health authorities, irrespective of the severity of the initial infection. A harmonized examination protocol has been implemented, consisting of detailed assessments of medical history, physical examinations, and the collection of multiple biosamples (e.g., serum, plasma, saliva, urine) for future analyses. In addition, patient-reported perception of the impact of local pandemic-related measures and infection on quality-of-life are obtained.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">As of July 2021, in total 6813 individuals infected in 2020 have been invited into the COVIDOM-study. Of these, about 36% wished to participate and 1295 have already been examined at least once.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">NAPKON-POP COVIDOM-study complements other Long COVID studies assessing the long-term consequences of an infection with SARS-CoV-2 by providing detailed health data of population-based samples, including individuals with various degrees of disease severity.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Registered at the German registry for clinical studies (DRKS00023742).</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Horn</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0494-6090</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Krist</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine, Epidemiology and Health Economics, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lieb</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montellano</LastName><ForeName>F A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohls</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haas</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelbrich</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolay-Gehrig</LastName><ForeName>S J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morbach</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Comprehensive Heart Failure Center, University and University Hospital W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine I, University Hospital W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reese</LastName><ForeName>J P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xf6;rk</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Comprehensive Heart Failure Center, University and University Hospital W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine I, University Hospital W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fricke</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine, Epidemiology and Health Economics, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoller</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Tropical and Public Health Institute, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triller</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kretzler</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf6;nnefarth</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Von Kalle</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willich</LastName><ForeName>S N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine, Epidemiology and Health Economics, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurth</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Department of Medicine I, University Medical Centre Hamburg-Eppendorf, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbeis</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witzenrath</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Lung Research (DZL), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahmer</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Stra&#xdf;e 3, 24105, Kiel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Lung Research (DZL), Airways Research Center North (ARCN), Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermes</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krawczak</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics and Statistics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinke</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Stra&#xdf;e 3, 24105, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maetzler</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franzenburg</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Laboratory Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Chemistry and Institute for Clinical Molecular Biology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enderle</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flinspach</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Stra&#xdf;e 3, 24105, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vehreschild</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Department 2, Hematology/Oncology and Infectious Diseases, University Hospital of Frankfurt, Frankfurt, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department I for Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schons</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department I for Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Illig</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hannover Medical School, Hannover Unified Biobank, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anton</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, Helmholtz Center Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ungeth&#xfc;m</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finkenberg</LastName><ForeName>B C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Public Health, District Office W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gehrig</LastName><ForeName>M T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Public Health, District Office Schweinfurt, Schweinfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savaskan</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Public Health, District Office Berlin-Neuk&#xf6;lln, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Heuschmann</LastName><ForeName>P U</ForeName><Initials>PU</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany. epidemiologie-sekretariat@uni-wuerzburg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Trial Center W&#xfc;rzburg, University Hospital W&#xfc;rzburg, Wurzburg, Germany. epidemiologie-sekretariat@uni-wuerzburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Keil</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of W&#xfc;rzburg, Julius Maximilian University of W&#xfc;rzburg, Wurzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Social Medicine, Epidemiology and Health Economics, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Institute of Health, Bavarian Health and Food Safety Authority, Bad Kissingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Schreiber</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Stra&#xdf;e 3, 24105, Kiel, Germany. s.schreiber@mucosa.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>DRKS</DataBankName><AccessionNumberList><AccessionNumber>DRKS00023742</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>01KX2021</GrantID><Agency>bundesministerium f&#xfc;r bildung und forschung</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Internal medicine</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neurological</Keyword><Keyword MajorTopicYN="N">On-site examination</Keyword><Keyword MajorTopicYN="N">Population-based</Keyword><Keyword MajorTopicYN="N">Sars-CoV-2</Keyword></KeywordList><CoiStatement>Caroline Morbach reports research cooperation with the University of W&#xfc;rzburg and Tomtec Imaging Systems funded by a research grant from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, Germany; advisory and speakers honoraria as well as travel grants from AKCEA, Alnylam, Amgen, Boehringer Ingelheim, EBR Systems Orion Pharma, Pfizer, SOBI, and Tomtec; principal investigator in trials sponsored by Alnylam and AstraZeneca; financial support from the interdisciplinary center for clinical research&#x2014;IZKF W&#xfc;rzburg (advanced clinician-scientist program).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34642875</ArticleId><ArticleId IdType="pmc">PMC8508400</ArticleId><ArticleId IdType="doi">10.1007/s15010-021-01707-5</ArticleId><ArticleId IdType="pii">10.1007/s15010-021-01707-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sahanic S, Sonnweber T, Pizzini A, Widmann G, Luger A, Aichner M, et al. Late Breaking Abstract - Persisting pulmonary impairment following severe SARS-CoV-2 infection, preliminary results from the CovILD study. Eur Respir J. 2020;56: Suppl. 64, 4143. 10.1183/13993003.congress-2020.4143</Citation></Reference><Reference><Citation>Al Chikhanie Y, Verges S, Herengt F, Veale D. Late breaking abstract - the weekly recovery of physical capacities in COVID-19 patients during post-extubation pulmonary rehabilitation. Eur Respir J. 2020;56:938.</Citation></Reference><Reference><Citation>Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO COVID-19 Explorer Geneva: World Health Organization; 2020 22/04/2021. https://worldhealthorg.shinyapps.io/covid/.</Citation></Reference><Reference><Citation>Kurth F, Roennefarth M, Thibeault C, Corman V, Muller-Redetzky H, Mittermaier M, et al. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19) Infection. 2020;48:619&#x2013;626. doi: 10.1007/s15010-020-01464-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01464-x</ArticleId><ArticleId IdType="pmc">PMC7293426</ArticleId><ArticleId IdType="pubmed">32535877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis 04/15/2021. https://www.researchsquare.com/article/rs-266574/v1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini M, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med. 2021;8:392. doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F, Lam K, Sounderajah V, Clarke J, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinMed. 2021;36:100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Martimbianco A, Pacheco R, Bagattini A, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75:e14357. 10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T, Weitzer D. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Med Lith. 2021;57:418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S, Tavahomi M, Zanjari N, Ebrahimi-Takamjani I, Amiri-Arimi S. Physical and mental health complications post-COVID-19: scoping review. J Psychosom Res. 2021;147:110525. doi: 10.1016/j.jpsychores.2021.110525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2021.110525</ArticleId><ArticleId IdType="pmc">PMC8133797</ArticleId><ArticleId IdType="pubmed">34051516</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens D, Hastie C, et al. Characterising long-term covid-19: a rapid living systematic review. Preprint. 2020.</Citation></Reference><Reference><Citation>Chun H, Coutavas E, Pine A, Lee A, Yu V, Shallow M, et al. Immunofibrotic drivers of impaired lung function in post-COVID-19 syndrome. Preprint. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410030</ArticleId><ArticleId IdType="pubmed">34111030</ArticleId></ArticleIdList></Reference><Reference><Citation>Darley D, Dore G, Cysique L, Wilhelm K, Andresen D, Tonga K, et al. Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection. Med J Aust. 2021;214:279&#x2013;280. doi: 10.5694/mja2.50963.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.50963</ArticleId><ArticleId IdType="pmc">PMC8014234</ArticleId><ArticleId IdType="pubmed">33657671</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein A, Amin M, Saad M, Zayan H, Abdelsayed M, et al. Determinants of persistent post COVID-19 symptoms: value of a novel COVID-19 symptoms score. Egypt J Bronchol. 2021;15:1&#x2013;8. doi: 10.1186/s43168-020-00049-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz Y, Van Herck M, Delbressine J, Vaes A, Meys R, Machado F, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6: 00542&#x2013;2020. 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J, Myall K, Lam J, Mason T, Mukherjee B, West A, et al. Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 2021;76:408&#x2013;411. doi: 10.1136/thoraxjnl-2020-215861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215861</ArticleId><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Vaira L, Lechien J, Safarian M, Saussez S, et al. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2021;59:26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73:e826&#x2013;e829. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampl B, Buczovsky M, Martin G, Schmied H, Leitzmann M, Salzberger B. Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases. Infection. 2021;49:661&#x2013;669. doi: 10.1007/s15010-021-01580-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01580-2</ArticleId><ArticleId IdType="pmc">PMC7934115</ArticleId><ArticleId IdType="pubmed">33666894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Leon-Ramirez J, Andres M, Ramos J, Arenas-Jimenez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Poncet-Megemont L, Paris P, Tronchere A, Salazard J, Pereira B, Dallel R, et al. High prevalence of headaches during Covid-19 infection: a retrospective cohort study. Headache. 2020;60:2578&#x2013;2582. doi: 10.1111/head.13923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13923</ArticleId><ArticleId IdType="pmc">PMC7436456</ArticleId><ArticleId IdType="pubmed">32757419</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V, Carerj M, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M, Ferdous M, Islam U, Mosaddek A, Potenza M, Pardhan S. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health. 2021;18:1453. doi: 10.3390/ijerph18041453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041453</ArticleId><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57:2003481. https://doi.org/10.1183/13993003.03481-2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, Sheill G, Dyer A, O'Kelly B, et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18:997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer A, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS&#xa0;One. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinkmann F, Muller M, Reif A, Kahn N, Kreuter M, Trudzinski F, et al. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. Eur Respir J. 2021;57:2003002. doi: 10.1183/13993003.03002-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03002-2020</ArticleId><ArticleId IdType="pmc">PMC7821834</ArticleId><ArticleId IdType="pubmed">33479105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L, Hopkins C, Petrocelli M, Lechien J, Chiesa-Estomba C, Salzano G, et al. Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020;134:703&#x2013;709. doi: 10.1017/S0022215120001826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120001826</ArticleId><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters J, Brink M, Schoon Y, Bleeker-Rovers C, Schers H, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020;73:e1089&#x2013;e1098. 10.1093/cid/ciaa1750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75:e13746. doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Aute GAC-P. Persistent symptoms in patients after acute COVID-19. JAMA J Am Med Assoc. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Shilo S, Rossman H, Kalkstein N, Marcus K, Barer Y, et al. Longitudinal symptom dynamics of COVID-19 infection. Nat Commun. 2020;11:1&#x2013;10. doi: 10.1038/s41467-020-20053-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20053-y</ArticleId><ArticleId IdType="pmc">PMC7718370</ArticleId><ArticleId IdType="pubmed">33277494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass J, Bartschke A, Lehne M, Essenwanger A, Rinaldi E, Rudolph S, et al. The German Corona Consensus Dataset (GECCO): a standardized dataset for COVID-19 research in university medicine and beyond. BMC Med Inform Decis Mak. 2020;20:1&#x2013;7. doi: 10.1186/s12911-020-01374-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-020-01374-w</ArticleId><ArticleId IdType="pmc">PMC7751265</ArticleId><ArticleId IdType="pubmed">33349259</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalfamo C, Heslin K, Shilen A, Khan S, Hunsaker J, Austhof E, et al. Design of the Arizona CoVHORT: a population-based COVID-19 cohort. Front Public Health. 2021;9:21. doi: 10.3389/fpubh.2021.620060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.620060</ArticleId><ArticleId IdType="pmc">PMC7902773</ArticleId><ArticleId IdType="pubmed">33643990</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly M, Robinson E. Acute and longer-term psychological distress associated with testing positive for COVID-19: longitudinal evidence from a population-based study of US adults 2021 15/04/2021. https://europepmc.org/article/PPR/PPR303913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8353189</ArticleId><ArticleId IdType="pubmed">34308807</ArticleId></ArticleIdList></Reference><Reference><Citation>Daga S, Fallerini C, Baldassarri M, Fava F, Valentino F, Doddato G, et al. Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research. Eur J Hum Genet. 2021;29:745&#x2013;759. doi: 10.1038/s41431-020-00793-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-020-00793-7</ArticleId><ArticleId IdType="pmc">PMC7811682</ArticleId><ArticleId IdType="pubmed">33456056</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>